These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 32936523)
61. Transmitted HIV-1 Drug Resistance in a Treatment-Naive Cohort of Recently Infected Individuals from Chennai, India. Nesakumar M; Haribabu H; Cheedarla N; Karunaianantham R; Kailasam N; Sathyamurthi P; Selvachithiram M; Tripathy SP; Hanna LE AIDS Res Hum Retroviruses; 2019 Aug; 35(8):775-779. PubMed ID: 31001987 [TBL] [Abstract][Full Text] [Related]
62. High Drug Resistance Levels Compromise the Control of HIV Infection in Pediatric and Adult Populations in Bata, Equatorial Guinea. Rodríguez-Galet A; Ventosa-Cubillo J; Bendomo V; Eyene M; Mikue-Owono T; Nzang J; Ncogo P; Gonzalez-Alba JM; Benito A; Holguín Á Viruses; 2022 Dec; 15(1):. PubMed ID: 36680067 [TBL] [Abstract][Full Text] [Related]
63. Transmission of drug-resistant HIV-1 is stabilizing in Europe. Vercauteren J; Wensing AM; van de Vijver DA; Albert J; Balotta C; Hamouda O; Kücherer C; Struck D; Schmit JC; Asjö B; Bruckova M; Camacho RJ; Clotet B; Coughlan S; Grossman Z; Horban A; Korn K; Kostrikis L; Nielsen C; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Riva C; Ruiz L; Salminen M; Schuurman R; Sonnerborg A; Stanekova D; Stanojevic M; Vandamme AM; Boucher CA J Infect Dis; 2009 Nov; 200(10):1503-8. PubMed ID: 19835478 [TBL] [Abstract][Full Text] [Related]
64. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children. Boerma RS; Boender TS; Sigaloff KC; Rinke de Wit TF; van Hensbroek MB; Ndembi N; Adeyemo T; Temiye EO; Osibogun A; Ondoa P; Calis JC; Akanmu AS J Int AIDS Soc; 2016; 19(1):21140. PubMed ID: 27836020 [TBL] [Abstract][Full Text] [Related]
65. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016. Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167 [TBL] [Abstract][Full Text] [Related]
67. Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. Baxter JD; Dunn D; White E; Sharma S; Geretti AM; Kozal MJ; Johnson MA; Jacoby S; Llibre JM; Lundgren J; HIV Med; 2015 Apr; 16 Suppl 1(0 1):77-87. PubMed ID: 25711326 [TBL] [Abstract][Full Text] [Related]
68. Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa. Boender TS; Hamers RL; Ondoa P; Wellington M; Chimbetete C; Siwale M; Labib Maksimos EE; Balinda SN; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Stevens W; Rinke de Wit TF; Sigaloff KC J Infect Dis; 2016 Sep; 214(6):873-83. PubMed ID: 27402780 [TBL] [Abstract][Full Text] [Related]
69. Primary drug resistance in South Africa: data from 10 years of surveys. Manasa J; Katzenstein D; Cassol S; Newell ML; de Oliveira T; AIDS Res Hum Retroviruses; 2012 Jun; 28(6):558-65. PubMed ID: 22251009 [TBL] [Abstract][Full Text] [Related]
70. Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa. van Zyl GU; Cotton MF; Claassen M; Abrahams C; Preiser W Pediatr Infect Dis J; 2010 Apr; 29(4):370-1. PubMed ID: 19935449 [TBL] [Abstract][Full Text] [Related]
71. Prevalence of transmitted HIV-1 drug resistance among young adults attending HIV counselling and testing clinics in Kigali, Rwanda. Mutagoma M; Ndahimana Jd; Kayirangwa E; Dahourou AG; Balisanga H; DeVos JR; McAlister D; Yang C; Bertagnolio S; Riedel DJ; Nsanzimana S Antivir Ther; 2016; 21(3):247-51. PubMed ID: 26458150 [TBL] [Abstract][Full Text] [Related]
72. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa. Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647 [TBL] [Abstract][Full Text] [Related]
73. Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in Maranhão State, northeast Brazil. Moura ME; Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM AIDS Res Hum Retroviruses; 2015 Feb; 31(2):250-4. PubMed ID: 25411830 [TBL] [Abstract][Full Text] [Related]
74. Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007. Hurt CB; McCoy SI; Kuruc J; Nelson JA; Kerkau M; Fiscus S; McGee K; Sebastian J; Leone P; Pilcher C; Hicks C; Eron J Antivir Ther; 2009; 14(5):673-8. PubMed ID: 19704170 [TBL] [Abstract][Full Text] [Related]
75. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil. Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362 [TBL] [Abstract][Full Text] [Related]
76. Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia. Loubet P; Charpentier C; Visseaux B; Nuta C; Adu E; Chapplain JM; Baysah M; Walters-Doe S; Tattevin P; Peytavin G; Yazdanpanah Y; Descamps D AIDS Res Hum Retroviruses; 2014 Sep; 30(9):863-6. PubMed ID: 24946849 [TBL] [Abstract][Full Text] [Related]
77. Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor. Spertilli Raffaelli C; Rossetti B; Paglicci L; Colafigli M; Punzi G; Borghi V; Pecorari M; Santoro MM; Penco G; Antinori A; Zazzi M; De Luca A; Zanelli G J Antimicrob Chemother; 2018 Sep; 73(9):2480-2484. PubMed ID: 29945251 [TBL] [Abstract][Full Text] [Related]
78. Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals. Arruda MB; Boullosa LT; Cardoso CC; da Costa CM; Alves CR; de Lima ST; Kaminski HT; Aleixo AW; Esposito AO; Cavalcanti AM; Riedel M; Couto-Fernandez JC; Ferreira SB; de Oliveira IC; Portal LE; Wolf HH; Fernandes SB; de M C Pardini MI; Feiteiro MV; Tolentino FM; Diaz RS; Lopes GI; Francisco RB; Véras NM; Pires AF; Franchini M; Mesquita F; Tanuri A; J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29504269 [TBL] [Abstract][Full Text] [Related]
79. Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan. Weng YW; Chen IT; Tsai HC; Wu KS; Tseng YT; Sy CL; Chen JK; Lee SS; Chen YS BMC Infect Dis; 2019 Aug; 19(1):741. PubMed ID: 31443633 [TBL] [Abstract][Full Text] [Related]
80. Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system. Readhead AC; Gordon DE; Wang Z; Anderson BJ; Brousseau KS; Kouznetsova MA; Forgione LA; Smith LC; Torian LV PLoS One; 2012; 7(8):e40533. PubMed ID: 22879878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]